Cohance promoters pledge 54.36% equity to secure term loans

Promoters of Cohance Lifesciences Limited have pledged 207.97 million equity shares, representing 54.36% of the total share capital, to secure term loan facilities availed from a consortium of lenders. The pledge was created in favour of Catalyst Trusteeship Limited, acting as the onshore security agent, on June 17, 2026. This encumbrance covers the cumulative shareholding of Berhyanda Limited and Jusmiral Holdings Limited, the promoter entities.

The disclosure was made under Regulation 29(1) read with Regulation 29(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The borrowing entities entered into a facility agreement dated June 11, 2026, with lenders including Barclays Bank Plc, Deutsche Bank AG, Singapore Branch, BNP PARIBAS, MUFG Bank, Ltd. Singapore Branch, and Standard Chartered Bank (Singapore) Limited.

Details of Pledge and Encumbrance

The first-ranking exclusive pledge secures facilities under the facility agreement. The specific shares pledged include 127.54 million shares (33.34% of total capital) held by Berhyanda Limited and 80.43 million shares (21.02% of total capital) held by Jusmiral Holdings Limited. The total voting capital of the target company stands at 382.57 million shares.

Promoter Entity	Shares Pledged	% of Total Share Capital
Berhyanda Limited	127,539,592	33.34%
Jusmiral Holdings Limited	80,434,990	21.02%
Total	207,974,582	54.36%

Covenants and Restrictions

Alongside the pledge, the promoters agreed to covenants effective June 16, 2026, which act as encumbrances over a larger holding of 219.93 million shares, or 57.49% of the total share capital. These covenants impose restrictions on the disposal of shares and the creation of any further security on the shareholding. The extended encumbrance covers the entire promoter holding, including 92.39 million shares (24.15%) held by Jusmiral Holdings Limited that are not part of the immediate pledge.

Furthermore, 100% of the shares held by the shareholders of the borrowing entities have been pledged in favour of CSCGlobal Capital Markets (Singapore) Pte. Ltd., the offshore security agent. This offshore pledge became effective on June 16, 2026. However, the shareholders of the borrowers have not created any direct encumbrance over the equity shares of Cohance Lifesciences Limited.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.92%	-4.16%	-5.19%	-23.37%	-59.80%	-15.38%

Promoters Berhyanda Limited and Jusmiral Holdings Limited have released the encumbrance over their combined 57.49% stake in Cohance Lifesciences Limited following the full repayment of notes on June 16, 2026. The release covers 219,930,170 equity shares, representing the entire shareholding of the promoters in the company, and is effective from June 16, 2026. The encumbrance was previously created through covenants and offshore pledge agreements under a Notes Purchase Agreement dated May 29, 2024.

The covenants had imposed restrictions on the disposal of shares and the maintenance of financial ratios. CSCGlobal Capital Markets (Singapore) Pte. Ltd. acted as the security agent for the transaction. The disclosure confirms that no direct encumbrance was created over the equity shares of the target company by the shareholders of the borrowers. The total equity share capital of the company stands at 382,567,140 equity shares of Rs. 1/- each, with total diluted share capital at 392,403,586 equity shares.